Sofia Kruchinova

Dr. Sofia Kruchinova

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2019 in The Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
SKSofia Kruchinova
Sofia Kruchinova
EKE. D. Kosmacheva
E. D. Kosmacheva
VPV. A. Porkhanov
V. A. Porkhanov
Objective: to give a comparative characterization of myocardial infarction with and without obstructive lesion of coronary arteries.Material and Methods. The study involved 4639 patients included in the first total register of acute coronary syndrome in the Krasnodar Territory for the first 12 months of register operation. A comparative analysis of patients with myocardial infarction with obstructive lesion and without obstructive lesion of coronary arteries was performed.Results. Between November 2016 and November 2017, 4453 patients with myocardial infarction with obstructive coronary disease, including 2261 men (50.8%) and 2192 women (49.2%) were enrolled in the register. The mean age of patients was 68.3±12.03 years (69.3±3.42 years in men; 63.4±7.35 years in women). The criteria for myocardial infarction without obstructive coronary artery disease were present in 186 people (4.1%), including 72 men (38.7%) and 114 women (72.3%). The average age of the patients was 54.2±4.53 years; age of men with myocardial infarction without obstructive coronary disease was 56.3±3.52 years; age of women was 52.1±3.12 years. The article presents a detailed comparative analysis of demographic, medical history, clinical-instrumental, and laboratory data of these patient groups. Conclusion. Compared with patients who had obstructive coronary changes, the cohort of patients with myocardial infarction without obstructive lesions of the coronary arteries was younger and included more female patients; among the risk factors in this group, smoking and arterial hypertension were significant; the rates of newly diagnosed diabetes mellitus and Q-positive myocardial infarction were higher. According to the analysis of echocardiographic data, significant decrease in global contractility of the left ventricular myocardium was less common; analysis of laboratory data showed that patients more often had low platelet count.

19 June 2022 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
OMO. V. Malyarevskaya
O. V. Malyarevskaya
Alim NamitokovAlim Namitokov
Alim Namitokov
SKSofia Kruchinova
Sofia Kruchinova
EKE. D. Kosmacheva
E. D. Kosmacheva
This review will present an analysis of the mechanisms of PCSK9 influence on lipid metabolism and its role in the development of cardiovascular pathology, an assessment of the effectiveness and safety of PCSK9 inhibitors, the place of PCSK9 inhibitors in the clinical recommendations of the European, Russian Cardiological Society and the American College of the Heart.

13 February 2019 in The Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
SKSofia Kruchinova
Sofia Kruchinova
EKE. D. Kosmacheva
E. D. Kosmacheva
SRS. A. Raff
S. A. Raff
VPV. A. Porkhanov
V. A. Porkhanov
The review presents a comparative analysis of data from patients with myocardial infarction with non-obstructive coronary arteries. Data were obtained from the total register of acute coronary syndrome in the Krasnodar Krai and were compared with data of foreign registers.

7 April 2023 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
SKSofia Kruchinova
Sofia Kruchinova
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
Alim NamitokovAlim Namitokov
Alim Namitokov
MGMilana Gendugova
Milana Gendugova
МКМария Карибова
Мария Карибова
EKElena Kosmacheva
Elena Kosmacheva
(1) Background. One of the causes of myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) is thrombus formation in situ followed by lysis, resulting in a morphologically normal angiogram but with an underlying prothrombotic state that is potentially predisposed to recurrence. Recent studies have shown that a subset of MINOCA patients may have thrombophilic conditions at screening. Objective: To compare the prothrombotic trend in MINOCA patients with that of subjects with MI and obstructive coronary arteries (MIOCA) by testing for known congenital thrombophilias and markers of coagulation activation. (2) Materials and methods. Screening included congenital thrombophilias (factor V Leiden; assessment of protein C, protein S, and antithrombin III) and eight genes. Of these, four genes represented the folate pathway enzymes: MTHFR 677 C>T (rs1801133), MTHFR 1298 A>C (rs1801131), MTR 2756 A>G (rs1805087), and MTRR 66 A>G (rs1801394). The other four genes represented the blood coagulation system: F13 (163 G>T) rs5985, F1 (−455 G>A) rs1800790, GP IIb–IIIa (1565 T>C) rs5918, and PAI-I (−675 5G>4G) rs1799889. Additionally, we examined the levels of homocysteine and lipoprotein (LP) (a). (3) Results. Our study included 269 patients: 114 MINOCA patients and 155 MIOCA patients with lesions of one coronary artery. The frequencies of polymorphisms in the genes of the blood coagulation system and the folate pathway did not differ between the groups. The following genes were associated with in-hospital mortality in the MINOCA group: MTHFR 1298 A>C rs1801131 (OR 8.5; 95% CI 1.67–43.1) and F1 (−455 G>A) rs1800790 (OR 5.8; 95% CI 1.1–27.8). In the MIOCA group, the following genes were associated with in-hospital mortality: MTHFR 1298 A>C rs1801131 (OR 9.1; 95% CI 2.8–28.9), F1 (−455 G>A) rs1800790 (OR 11.4; 95% CI 3.6–35.9), GP IIb–IIIa (1565 T>C) rs5918 (OR 10.5; 95% CI 3.5–30.8), and PAI-I (−675 5G>4G) rs1799889 (OR 12.9; 95% CI 4.2–39.7). We evaluated long-term outcomes (case fatality rate, recurrent MI, and stroke) over a period of 12 months in both groups. The variables associated with these outcomes were laboratory parameters, such as protein C deficiency, hyperhomocysteinemia, and a content of LP (a) > 30 mg/dL. However, we did not reveal the prognostic value of polymorphisms of the studied genes representing the blood coagulation system and the folate pathway. (4) Conclusion. We established no statistically significant differences between the MINOCA and MIOCA groups in the prevalence of congenital thrombophilias and the prevalence of folate pathway enzyme genes and blood coagulation system genes. The MTHFR 1298 A>C (rs1801131) and F1 (−455 G>A) rs1800790 genes were associated with in-hospital mortality in both groups. More significant prognostic factors in both groups during the one-year period were protein C deficiency, hyperhomocysteinemia, and LP (a) > 30 mg/dL.

11 May 2023 in Data
Verified
Journal Article
Open access
PDF file
Vladimir ShvartzVladimir Shvartz
Vladimir Shvartz
ESEldar Sizhazhev
Eldar Sizhazhev
MSMaria Sokolskaya
Maria Sokolskaya
SKSvetlana Koroleva
Svetlana Koroleva
Soslan Taisumovich EnginoevSoslan Taisumovich Enginoev
Soslan Taisumovich Enginoev
EGElena Golukhova
Elena Golukhova
Many previous studies have demonstrated that transcutaneous vagus nerve stimulation (VNS) has the potential to exhibit therapeutic effects similar to its invasive counterpart. An objective assessment of VNS requires a reliable biomarker of successful vagal activation. Although many potential biomarkers have been proposed, most studies have focused on heart rate variability (HRV). Despite the physiological rationale for HRV as a biomarker for assessing vagal stimulation, data on its effects on HRV are equivocal. To further advance this field, future studies investigating VNS should contain adequate methodological specifics that make it possible to compare the results between studies, to replicate studies, and to enhance the safety of study participants. This article describes the design and methodology of a randomized study evaluating the effect of short-term noninvasive stimulation of the auricular branch of the vagus nerve on parameters of HRV. Primary records of rhythmograms of all the subjects, as well as a dataset with clinical, instrumental, and laboratory data of all the current study subjects are in the public domain for possible secondary analysis to all interested researchers. The physiological interpretation of the obtained data is not considered in the article.

27 September 2024 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
Alim NamitokovAlim Namitokov
Alim Namitokov
SKSofia Kruchinova
Sofia Kruchinova
MGM. N. Gendugova
M. N. Gendugova
MGM. V. Gradovskaya
M. V. Gradovskaya
IGI. V. Gilevich
I. V. Gilevich
Objective: to evaluate the impact of lipoprotein (a) [Lp(a)] levels on long-term outcomes in patients with acute coronary syndrome (ACS) and single-vessel coronary artery disease. Materials and methods: the study included 110 patients diagnosed with ACS and single-vessel coronary artery disease. Patients were divided into two groups based on Lp(a) levels: Lp(a) > 50 mg/dL (n=22) and Lp(a) < 50 mg/dL (n=88). Primary outcomes included survival and the frequency of recurrent cardiovascular events at 6, 12, and 36 months. Statistical analysis included t-test, chi-square test, Kaplan-Meier method, and Cox multivariate regression. Results: at 36 months, patients with high Lp(a) levels had significantly higher rates of recurrent myocardial infarctions (50% vs. 34.1%, p < 0.001) and all-cause mortality (59.1% vs. 23.9%, p < 0.001) compared to patients with normal Lp(a) levels. Conclusion: high Lp(a) levels are a significant prognostic factor for worse long-term outcomes in patients with ACS and single-vessel coronary artery disease. Measuring Lp(a) levels may improve management strategies for these patients.